SKU(재고 관리 코드):MAA053Hu22
Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.
Product No.
MAA053Hu22
Organism Species
Homo sapiens (Human).
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
n/a
Ig Isotype
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
n/a
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
1mg/mL
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against IGFBP2. It has been selected for its ability to recognize IGFBP2 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Magazine | Citations |
British journal of cancer | A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. pubmed:28664912 |
Experimental and Therapeutic Medicine | Identification and validation of differentially expressed proteins in serum of CSU patients with different duration of wheals using an iTRAQ labeling, 2D‑LC‑MS/MS Doi: 10.3892/etm.2018.6818 |
Nutrition and Cancer | Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer Pubmed: 32286106 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA053Hu01 | Recombinant Insulin Like Growth Factor Binding Protein 2 (IGFBP2) | Positive Control; Immunogen; SDS-PAGE; WB. |
APA053Hu61 | Active Insulin Like Growth Factor Binding Protein 2 (IGFBP2) | Cell culture; Activity Assays. |
EPA053Hu61 | Eukaryotic Insulin Like Growth Factor Binding Protein 2 (IGFBP2) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA053Hu01 | Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2) | WB; IHC |
MAA053Hu22 | Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2) | WB; IHC; ICC; IP. |
SEA053Hu | ELISA Kit for Insulin Like Growth Factor Binding Protein 2 (IGFBP2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA053Hu | Magnetic Luminex Assay Kit for Insulin Like Growth Factor Binding Protein 2 (IGFBP2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |